https://thebostonexaminer.com/article/911441619-debo-ray-sings-of-pain-promise-in-self-revealing-album-and-release-show The Boston Examiner en PressRelease 2026-05-08T18:54:37+00:00 Debo Ray Sings of Pain & Promise in Self-Revealing Album and Release Show https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851421-echoes-embers-cover-art-2800x2800.jpeg https://thebostonexaminer.com/article/911381655-2026-lowell-kinetic-sculpture-race-sept-19-a-celebration-of-s-t-e-a-m-innovation The Boston Examiner en PressRelease 2026-05-08T14:32:13+00:00 2026 Lowell Kinetic Sculpture Race Sept. 19 -A Celebration of S.T.E.A.M. Innovation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851194-moose-on-merrimack-at-lksr-4000x2667.jpeg https://thebostonexaminer.com/article/911523470-ispecimen-inc-announces-pricing-of-approximately-2-5-million-private-placement The Boston Examiner en PressRelease 2026-05-09T01:04:00+00:00 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement https://ml.globenewswire.com/media/MWMwZjE2YjEtYTE0Yy00NGY4LTljODctMDk0YTk0ZmI5N2E5LTUwMDEzMTIwMy0yMDI2LTA1LTA5LWVu/tiny/iSpecimen-Inc-.png https://thebostonexaminer.com/article/911162356-broadsat-and-rsat-unveil-defense-grade-ai-powered-hybrid-leo-geo-satellite-network-to-close-the-global-connectivity-gap The Boston Examiner en PressRelease 2026-05-08T12:05:11+00:00 BroadSat and RSAT Unveil Defense-Grade, AI-Powered Hybrid LEO/GEO Satellite Network to Close the Global Connectivity Gap https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850432-broadsat-875x285.png https://thebostonexaminer.com/article/911474423-outbound-sales-pro-and-parakeet-promotes-andrew-aj-kissh-to-head-of-marketing The Boston Examiner en PressRelease 2026-05-08T20:57:00+00:00 Outbound Sales Pro and Parakeet Promotes Andrew "AJ" Kissh to Head of Marketing https://pressranger.s3.us-west-1.amazonaws.com/3239968/Welcome-to-the-flock.png https://thebostonexaminer.com/article/911474559-acronis-y-netfusion-teamup-se-asocian-para-lanzar-un-laboratorio-de-rob-tica-steam-para-estudiantes-vulnerables-en-costa-rica The Boston Examiner en PressRelease 2026-05-08T20:39:22+00:00 Acronis y NetFusion #TeamUp se asocian para lanzar un laboratorio de robótica STEAM para estudiantes vulnerables en Costa Rica https://ml.globenewswire.com/media/f70be083-b458-42fe-b575-529c5c261088/small/acronis-svg-png.png https://thebostonexaminer.com/article/911474191-fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-08T20:30:00+00:00 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://thebostonexaminer.com/article/911474273-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-08T20:05:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://thebostonexaminer.com/article/911270867-silicon-valley-ai-film-festival-launches-boston-regional-division-connecting-ai-cinema-and-cross-cultural-creativity The Boston Examiner en PressRelease 2026-05-08T04:57:26+00:00 Silicon Valley AI Film Festival Launches Boston Regional Division, Connecting AI, Cinema, and Cross-Cultural Creativity https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850839-2026film-1950x1296.png https://thebostonexaminer.com/article/911404294-city-year-americorps-members-gain-access-to-college-credit-for-prior-learning-achieved-through-service-expanding-pathways-to-higher-education The Boston Examiner en PressRelease 2026-05-08T14:52:01+00:00 City Year AmeriCorps Members Gain Access to College Credit for Prior Learning Achieved Through Service, Expanding Pathways to Higher Education https://ml.globenewswire.com/media/OGE1OWM3YzItNGIxZi00OWEwLTg1Y2QtNDI0NGViNjRkOTE3LTExMTA0NjctMjAyNi0wNS0wOC1lbg==/tiny/City-Year.png https://thebostonexaminer.com/article/911386524-acronis-and-netfusion-teamup-to-launch-steam-robotics-lab-for-underserved-students-in-costa-rica The Boston Examiner en PressRelease 2026-05-08T14:01:39+00:00 Acronis and NetFusion #TeamUp to Launch STEAM Robotics Lab for Underserved Students in Costa Rica https://ml.globenewswire.com/media/90fda8a1-4feb-4117-bcdd-d9862f39748e/medium/acronis-and-netfusion-teamup-to-launch-steam-robotics-lab-fo.jpg https://thebostonexaminer.com/article/911386518-ai-technology-transforms-cannabis-industry-as-leading-operators-drive-adoption-to-enhance-yields-and-compliance The Boston Examiner en PressRelease 2026-05-08T13:52:16+00:00 AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://thebostonexaminer.com/article/911370850-alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma The Boston Examiner en PressRelease 2026-05-08T13:10:00+00:00 Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://thebostonexaminer.com/article/911370826-alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent The Boston Examiner en PressRelease 2026-05-08T13:00:00+00:00 Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://thebostonexaminer.com/article/911370802-stran-company-schedules-first-quarter-2026-financial-results-and-business-update-conference-call The Boston Examiner en PressRelease 2026-05-08T12:30:00+00:00 Stran & Company Schedules First Quarter 2026 Financial Results and Business Update Conference Call https://ml.globenewswire.com/media/a5974fda-fa3a-4525-a4be-0ffb58879436/small/stran-new-logo-jpg.jpg https://thebostonexaminer.com/article/911205855-stark-moving-and-storage-won-2026-boston-business-excellence-award-for-outstanding-relocation-services-in-greater-boston The Boston Examiner en PressRelease 2026-05-07T22:38:10+00:00 Stark Moving and Storage Won 2026 Boston Business Excellence Award for Outstanding Relocation Services in Greater Boston https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24466072-stark-movers-boston-220x78.png https://thebostonexaminer.com/article/911102923-social-isolation-poses-health-risk-comparable-to-smoking-worcester-library-program-offers-a-powerful-local-solution The Boston Examiner en PressRelease 2026-05-07T20:49:45+00:00 Social Isolation Poses Health Risk Comparable to Smoking—Worcester Library Program Offers a Powerful Local Solution https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850252-senior-group-reading-together-1890x1534.png https://thebostonexaminer.com/article/911172226-boston-gynecomastia-specialists-establishes-itself-as-the-region-s-premier-dedicated-male-breast-reduction-practice The Boston Examiner en PressRelease 2026-05-07T20:19:54+00:00 Boston Gynecomastia Specialists establishes itself as the region’s premier dedicated Male Breast Reduction practice https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850561-chestsculpt-transformation-960x1004.png https://thebostonexaminer.com/article/911307449-update-on-fda-priority-review-of-leqembi-iqlik-lecanemab-irmb-subcutaneous-injection-as-a-starting-dose-for-early-alzheimer-s-disease The Boston Examiner en PressRelease 2026-05-08T06:30:00+00:00 Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://thebostonexaminer.com/article/911239138-odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering The Boston Examiner en PressRelease 2026-05-08T00:44:45+00:00 Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/6da00a97-4976-4d32-9f38-cff9c4f091cf/small/odysseylogo-color-highres-png.png https://thebostonexaminer.com/article/911222901-cue-biopharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-07T23:07:21+00:00 Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://thebostonexaminer.com/article/911190966-lemaitre-to-present-at-the-bank-of-america-healthcare-conference The Boston Examiner en PressRelease 2026-05-07T21:15:30+00:00 LeMaitre to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://thebostonexaminer.com/article/911190000-xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-07T20:30:00+00:00 Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://thebostonexaminer.com/article/911190160-merlin-inc-to-report-first-quarter-2026-results-on-may-14-2026 The Boston Examiner en PressRelease 2026-05-07T20:30:00+00:00 Merlin, Inc. to Report First Quarter 2026 Results on May 14, 2026 https://ml.globenewswire.com/media/30f04298-e7db-4dfa-9a1e-8c6452cdfce0/small/merlin-logo-jpg.jpg https://thebostonexaminer.com/article/911173700-jade-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://thebostonexaminer.com/article/911173756-pyxis-oncology-appoints-nelson-azoulay-as-chief-business-officer The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://thebostonexaminer.com/article/911173806-camp4-reports-first-quarter-2026-financial-results-and-corporate-highlights The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://thebostonexaminer.com/article/911173903-organogenesis-holdings-inc-reports-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg https://thebostonexaminer.com/article/911173922-cargurus-announces-first-quarter-2026-results The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 CarGurus Announces First Quarter 2026 Results https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png https://thebostonexaminer.com/article/911174050-definitive-healthcare-reports-financial-results-for-first-quarter-2026 The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Definitive Healthcare Reports Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/b8026e6c-2ebe-4247-9167-1eb9d2f0103d/small/definitivehealthcare-logo-fullcolor-png.png https://thebostonexaminer.com/article/911174243-imagenebio-reports-first-quarter-2026-financial-results-and-provides-img-007-program-update The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg https://thebostonexaminer.com/article/911174303-werewolf-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-updates The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates https://ml.globenewswire.com/media/afa0b662-d7e8-40d2-aad4-824ccfcaddd5/small/wolf-jpg.jpg https://thebostonexaminer.com/article/911174452-nano-dimension-announces-financial-results-for-the-first-quarter-2026 The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Nano Dimension Announces Financial Results for the First Quarter 2026 https://ml.globenewswire.com/media/dd1b96fc-0b19-4125-bdcb-867c52c8f415/small/logo-nd-nw-png.png https://thebostonexaminer.com/article/911174492-cerence-ai-delivers-strong-q2-fy26-results-with-revenue-above-guidance-raises-and-refines-full-year-outlook The Boston Examiner en PressRelease 2026-05-07T20:05:00+00:00 Cerence AI Delivers Strong Q2 FY26 Results with Revenue Above Guidance; Raises and Refines Full-Year Outlook https://ml.globenewswire.com/media/873690ee-866c-4dea-9808-10aecc02890f/small/cerence-ai-logo-full-color-h-1-png.png https://thebostonexaminer.com/article/911173718-bluejay-diagnostics-provides-first-quarter-2026-corporate-update The Boston Examiner en PressRelease 2026-05-07T20:01:00+00:00 Bluejay Diagnostics Provides First Quarter 2026 Corporate Update https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg https://thebostonexaminer.com/article/911173810-celldex-reports-first-quarter-financial-results-and-provides-corporate-update The Boston Examiner en PressRelease 2026-05-07T20:01:00+00:00 Celldex Reports First Quarter Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://thebostonexaminer.com/article/911173830-tectonic-therapeutic-announces-first-quarter-2026-financial-results-and-recent-business-highlights The Boston Examiner en PressRelease 2026-05-07T20:01:00+00:00 Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/7c13d2a1-2971-4ab0-a4b5-608923316546/small/tectonic-logo-full-color-png.png https://thebostonexaminer.com/article/911174023-voyager-reports-first-quarter-2026-financial-and-operating-results The Boston Examiner en PressRelease 2026-05-07T20:01:00+00:00 Voyager Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://thebostonexaminer.com/article/911174028-akamai-reports-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-05-07T20:01:00+00:00 Akamai Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://thebostonexaminer.com/article/911174767-acumen-pharmaceuticals-to-participate-in-the-bank-of-america-securities-2026-health-care-conference The Boston Examiner en PressRelease 2026-05-07T20:00:00+00:00 Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png